Gilde Buy Out rebrands as Rivean Capital

The GP's team and strategy will remain the same, according to a statement, although the firm will now establish itself as an independent entity.

Rivean Capital (formerly Gilde Buyout) was founded in 1982. The GP previously shared the "Gilde" portion of its name with Gilde Healthcare and Gilde Equity Management. Rivean has five offices across Belgium the Netherlands, Germany, Switzerland and Italy with a team of more than 30 investment professionals.

The GP held a final close for its latest flagship fund in 2019 on EUR 1.4bn. The fund was expected to back 17-20 companies and to deploy average equity tickets of EUR 75m, according to Unquote Data.

Rivean targets European companies with an enterprise value of EUR 100m-500m, aiming to back businesses with transformation potential and the possibility of global M&A and organic growth initiatives. The GP invests in situations including public-to-private deals, carveouts, spin-offs, and buy-and-build deals.

Rivean Capital's recent activity includes the acquisition of Ardian Growth-backed ProduceShop earlier in February as well as its acquisition of a minority stake in Init, a digital transformation consultancy backed by Emeram Capital Partners in December 2021.

In January 2022, Unquote sister publication Mergermarket compiled a list of the DACH region companies considered to be the most likely to come to market this year in its DACH M&A Pipeline Explorer. Based on Dealogic's Likely to Issue (LTI) predictive algorithm and commentary from dealmakers, businesses including Rivean-backed jewellery distributor Amor were cited as potential sale candidates. The GP has owned the company since 2016, when it acquired the business from 3i.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• GPs
• Benelux
• DACH
• Southern Europe
• Gilde Buy Out Partners
• Belgium